Vital Compliance Insights
Healthcare regulatory compliance resource
Episodes
14 episodes
CMS Antipsychotic QM - Part 2 - Steps For Safer Antipsychotic Use
We map a systems approach to antipsychotic use in nursing homes, from admission screening to documentation, coding, and survey readiness. Our goal is a practical stewardship model that protects residents, preserves data integrity, and withstand...
•
24:27
Understanding How CMS Will Track Antipsychotic Use In Nursing Homes - Part I
We unpack how CMS will monitor antipsychotic use in nursing homes, why the national average is changing, and what datasets will be cross-checked to produce public quality measures. We set the stage for part two, where we dig into practical step...
•
6:33
From OIG Guidance To Actionable Dashboards For Resident Safety
We trace how OIG’s guidance elevates patient safety and quality from ideals to daily compliance work, and share lessons from Corporate Integrity Agreements that separate paper programs from living systems. Practical tools, clear dashboards, and...
•
20:49
How OIG Wants Nursing Facilities To Build Risk‑Based, Competency‑Driven Education
We unpack the OIG’s nursing facility guidance on compliance education and show how to move from generic modules to risk‑based, competency‑driven training that protects residents. We connect risk assessments, CMS alignment, and real‑world method...
•
24:09
How A Federal Shutdown Weakens Nursing Home Oversight And What It Means For Residents
We examine how the federal shutdown disrupts nursing home oversight, why CMS triaged surveys to emergencies, and the risks created by fewer inspectors and furloughed staff. We share steps facilities can take to protect residents, drawing lesson...
•
11:10
Why Active Medical Director Engagement Protects Residents And Your Facility
We examine how CMS F841 and new OIG oversight raise expectations for nursing home medical directors, demanding visible engagement, better policies, and data-informed leadership. We share field lessons on antipsychotics, facility assessment, and...
•
20:55
Navigating MDS Accuracy in Long-Term Care
Accurate MDS completion has become a regulatory lightning rod as the OIG and CMS intensify their scrutiny of long-term care documentation. This shift isn't merely procedural—it signals a comprehensive effort to identify potential fraud and ensu...
•
25:56
OIG - Compliance Committee, Risk Assessment & Policy/Procedures
OIG 2023-2024 Compliance Guidance for Long Term Care Facilities is summarized to highlight importance of a compliance committee and the responsibility to assist the chief compliance officer to develop a robust facility risk assessment. From tha...
•
14:11
OIG focus on Chief Compliance Officer Role
In this episode, I will discuss the OIG November 2023 Compliance Officer Roles and Responsibilities guidance. The compliance officer has a responsibility to develop policies and procedures, conduct risk assessments, provide education and traini...
•
Season 1
•
Episode 2
•
15:03
OIG Compliance Guidance Overview 2023-2024 for Long Term Care Facilities
In this podcast episode, the host discusses the 2023 and 2024 updates to OIG's compliance program guidance (CPGs). These updates include a move to publishing the CPGs on the OIG website and the addition of a section on quality and patient safet...
•
Season 1
•
Episode 1
•
14:03
CMS Revisions to Psychotropic Medication Use
Skilled nursing facilities are facing changes in CMS survey guidance regarding unnecessary use of psychotropic medications. CMS is closely monitoring the use of these medications, which can be considered chemical restraints, and is asking...
•
35:09
CMS 2025 Long Term Care Regulatory Overview
SummaryThe CMS has released updated guidance on the long-term care survey process, focusing on accuracy of the MDS, medical director responsibilities, psychotropic medications and chemical restraints. In addition, the CMS issued clarific...
•
Season 1
•
Episode 1
•
21:32